Aurora Cannabis (ACB) Expected to Announce Earnings on Wednesday

Aurora Cannabis (NASDAQ:ACB) will likely be releasing its Q2 2027 results before the market opens on Wednesday, November 4th. Analysts expect the company to post earnings of ($0.03) per share and revenue of $50.68 million for the quarter. Parties may visit the company’s upcoming Q2 2027 earnings summary page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 8:00 AM ET.

Aurora Cannabis (NASDAQ:ACB) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.17. The firm had revenue of $47.62 million for the quarter, compared to analysts’ expectations of $47.45 million. On average, analysts expect Aurora Cannabis to post ($0.07) EPS for the current fiscal year and $0.06 EPS for the next fiscal year.

Aurora Cannabis Price Performance

Shares of ACB opened at $4.15 on Wednesday. The business has a 50-day moving average of $4.03 and a 200 day moving average of $3.55. Aurora Cannabis has a fifty-two week low of $2.56 and a fifty-two week high of $6.36.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Zacks Research lowered shares of Aurora Cannabis from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. BMO Capital Markets raised shares of Aurora Cannabis to a “hold” rating in a research report on Wednesday, August 5th. Wall Street Zen upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research note on Sunday, September 13th. Finally, Weiss Ratings raised Aurora Cannabis from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, October 2nd. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Aurora Cannabis Company Profile

Aurora Cannabis Inc is a Canadian cannabis company headquartered in Edmonton, Alberta. Founded in 2013, the company develops, produces, distributes and sells cannabis and cannabis-derived products for medical and adult-use markets. Its shares trade on the Toronto Stock Exchange and the Nasdaq under the symbol ACB.

Aurora’s product portfolio includes dried cannabis flower, pre-rolls, cannabis oils, softgels, vapes and other cannabis extracts. The company markets products through brands such as Aurora, San Rafael ’71, Daily Special and CanniMed, with offerings varying by market and applicable regulations.

The company serves Canada’s regulated adult-use and medical cannabis markets and has expanded its medical cannabis business internationally.